BI-655066

Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Novartis
psoriasis
Boehringer Ingelheim
Pfizer
Xeljanz
Cosentyx
JNJ
Stelara
BI-655066
Amgen
AstraZeneca
Merck
Eli Lilly